Synektik S.A.
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics … Read more
Synektik S.A. (SNT) - Total Liabilities
Latest total liabilities as of December 2025: zł347.02 Million PLN
Based on the latest financial reports, Synektik S.A. (SNT) has total liabilities worth zł347.02 Million PLN as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Synektik S.A. - Total Liabilities Trend (2010–2025)
This chart illustrates how Synektik S.A.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Synektik S.A. Competitors by Total Liabilities
The table below lists competitors of Synektik S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ncs Testing Technology Co Ltd
SHE:300797
|
China | CN¥879.81 Million |
|
Shanghai Challenge Textile Co Ltd
SHE:002486
|
China | CN¥210.33 Million |
|
SNT Motiv Co Ltd
KO:064960
|
Korea | ₩259.97 Billion |
|
F.I.L.A. - Fabbrica Italiana Lapis ed Affini S.p.A
F:3S0
|
Germany | €552.46 Million |
|
Ningbo Ocean Shipping Co. Ltd. A
SHG:601022
|
China | CN¥2.56 Billion |
|
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
|
USA | $202.91 Million |
|
Qudian Inc
NYSE:QD
|
USA | $2.00 Billion |
|
Tianyang Hot Mel
SHG:603330
|
China | CN¥872.42 Million |
Liability Composition Analysis (2010–2025)
This chart breaks down Synektik S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.57 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Synektik S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Synektik S.A. (2010–2025)
The table below shows the annual total liabilities of Synektik S.A. from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | zł265.57 Million | +43.37% |
| 2024-12-31 | zł185.23 Million | +11.78% |
| 2023-12-31 | zł165.71 Million | +11.49% |
| 2022-12-31 | zł148.63 Million | +87.84% |
| 2021-12-31 | zł79.13 Million | +20.59% |
| 2020-12-31 | zł65.62 Million | +19.65% |
| 2019-12-31 | zł54.84 Million | +17.69% |
| 2018-12-31 | zł46.60 Million | -12.92% |
| 2017-12-31 | zł53.51 Million | +58.26% |
| 2016-12-31 | zł33.81 Million | -29.35% |
| 2015-12-31 | zł47.86 Million | -1.25% |
| 2014-12-31 | zł48.46 Million | -1.46% |
| 2013-12-31 | zł49.18 Million | +12.05% |
| 2012-12-31 | zł43.89 Million | +36.55% |
| 2011-12-31 | zł32.15 Million | +252.04% |
| 2010-12-31 | zł9.13 Million | -- |